Page last updated: 2024-10-17
bupropion and Colitis Gravis
bupropion has been researched along with Colitis Gravis in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Smoking cessation is associated with a 65% reduction in the risk of a relapse as compared with continued smokers, a similar magnitude to that obtained with immunosuppressive therapy." | 2.43 | Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. ( Cosnes, J; Johnson, GJ; Mansfield, JC, 2005) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Johnson, GJ | 1 |
| Cosnes, J | 1 |
| Mansfield, JC | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| A Randomized, Controlled, Open-label Study to Investigate the Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease[NCT01540942] | | 91 participants (Actual) | Interventional | 2011-11-30 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
1 review available for bupropion and Colitis Gravis